Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Switch to Oral Antibiotics in Gram-negative Bacteremia (SOAB); a Randomized, Open-label, Clinical Trial.

NCT04146922 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT04146922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04146922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Switch to Oral Antibiotics in Gram-negative Bacteremia (SOAB); a Randomized, Open-label, Clinical Trial.
Lead sponsor
Hamad Medical Corporation
Phase
Not applicable
Overall status
Completed
Start date
October 13, 2019
Completion date
July 30, 2023
Enrollment
176 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

citrobacter bacteraemia, enterobacter bacteraemia, escherichia coli bacteremia, klebsiella bacteraemia, proteus bacteraemia, serratia bacteraemia